CAC Software vs KardiaAI

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

CAC Software

by 4DMedical (Imbio CAC Software)

KardiaAI

by AliveCor

AI Verdict

While both tools leverage AI for cardiology, they address distinct aspects of cardiac health. Imbio's CAC Software focuses on quantifying coronary artery calcification from CT scans for cardiovascular risk assessment, whereas AliveCor's KardiaAI analyzes ambulatory ECG rhythms to detect various cardiac arrhythmias. Therefore, the choice between them depends on whether the clinical need is for structural risk assessment via imaging or electrical rhythm monitoring via ECG.

Choose CAC Software if…

Choose Imbio's CAC Software if your primary objective is to accurately quantify coronary artery calcification from non-contrast chest CT scans for detailed cardiovascular risk assessment. This tool provides automated Agatston scores, arterial age, and 3D visualizations, making it ideal for radiologists and cardiologists focused on identifying and stratifying patients at risk for coronary artery disease.

View CAC Software →

Choose KardiaAI if…

Choose KardiaAI if you require an FDA-cleared, AI-powered software library for analyzing ambulatory ECG rhythms to detect various cardiac conditions such as AFib, bradycardia, and tachycardia. Its robust API allows for seamless integration into mobile apps and other medical devices, making it best suited for continuous or on-demand heart rhythm monitoring and arrhythmia detection.

View KardiaAI →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	CAC Software	KardiaAI
Pricing	Unknown	Subscription-based for advanced features and services.
Deployment	Cloud-based (SaaS), integrates with PACS	Mobile app, cloud-based.
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

KardiaAI

While Tool A integrates into existing DICOM workflows, which is crucial for its target users, Tool B (via AliveCor's direct products) offers a highly accessible and user-friendly experience for a broader range of users, including patients, for capturing and understanding critical cardiac data. Its API also allows for flexible integration into various user interfaces, making its underlying AI widely usable.

Clinical Value

Tie

Both tools offer substantial and distinct clinical value. Tool A provides critical quantitative data for cardiovascular risk assessment from imaging by quantifying coronary artery calcification, aiding in preventative cardiology. Tool B offers accurate, real-time diagnostic insights for a range of arrhythmias from ECGs, crucial for early detection and management of cardiac conditions. Both are FDA-cleared and address significant clinical needs.

Pricing & Value

KardiaAI

Tool B offers transparent, subscription-based pricing with clear tiers, making it easy for users to understand the cost and value proposition. Tool A's 'contact for pricing' approach lacks this transparency, making it difficult for potential customers to assess value without direct engagement.

Enterprise Readiness

Tie

Both tools demonstrate robust enterprise readiness, including FDA clearance, HIPAA compliance, and BAA availability. Tool A offers flexible deployment options (cloud, on-premise, partner platforms) suitable for various healthcare IT infrastructures. Tool B's API-first Software as a Medical Device (SaMD) approach is highly adaptable for integration into diverse digital health ecosystems and partners with healthcare systems for broader deployment.

Innovation

KardiaAI

While both tools leverage deep learning for medical analysis, KardiaAI's approach as an API library for comprehensive, medical-grade ECG analysis, enabling broad integration and accessibility across various mobile and web platforms, represents a more disruptive and widely applicable innovation. AliveCor has been a leader in bringing AI-powered ECG analysis to personal devices and clinical settings.

Support & Docs

KardiaAI

AliveCor, the company behind KardiaAI, provides comprehensive and easily accessible support documentation and resources for its users, including FAQs, user manuals, and direct support channels, typically found on their website and within their applications. Imbio's support information for CAC Software is less transparent and readily available online from a general search.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	CAC Software	KardiaAI
Primary Function	Automated image post-processing for coronary artery calcification from non-contrast chest CT.	AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions.
Company	Imbio	AliveCor
Input Data Type	Non-contrast, chest computed tomography (CT)	Ambulatory ECG rhythms
Key Output/Analysis Focus	Quantification of calcification within coronary arteries, Agatston score, arterial age, calcified lesion mass and volume, 3D visualizations.	Detection of atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with PVCs, Sinus Rhythm with Wide QRS, Sinus Rhythm with SVE, ECG noise filtering.
Specialties	Cardiology, Radiology	Cardiology, Emergency Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring CAC Software and KardiaAI.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiac conditions or risk factors do these tools help physicians assess or detect?

Imbio's Coronary Artery Calcification (CAC) software is designed to help radiologists and cardiologists determine the location and calculate the amount of calcification within the coronary arteries from non-contrast chest CT scans, supporting risk assessment for coronary artery disease. KardiaAI by AliveCor is an AI software library for analyzing ambulatory ECG rhythms, detecting various cardiac conditions such as atrial fibrillation, bradycardia, tachycardia, normal sinus rhythm, Sinus Rhythm with Premature Ventricular Contractions (PVCs), Sinus Rhythm with Wide QRS, and Sinus Rhythm with Supraventricular Ectopy (SVE).

What type of patient data is required for analysis by each tool?

Imbio's CAC Software analyzes non-contrast chest computed tomography (CT) scans. KardiaAI by AliveCor requires ambulatory ECG rhythms for its AI-powered analysis.

How do these tools integrate into existing clinical workflows?

Imbio's CAC Software is designed to integrate into existing DICOM viewing workflows, automatically receiving image series, processing them, and returning results directly to PACS. KardiaAI by AliveCor is an API library intended for integration into mobile apps, web platforms, and other ECG devices and software, and can connect with clinical enterprise solutions like KardiaPro for remote patient monitoring and EHR integration.

What are the primary outputs or metrics provided by each tool?

Imbio's CAC Software provides quantitative outputs including the Agatston score, arterial age, calcified lesion mass, and volume, along with 3D visualizations and annotated images. KardiaAI provides detections of various heart rhythms and morphologies, such as atrial fibrillation, bradycardia, tachycardia, and normal sinus rhythm, as well as specific ectopic beats and rhythm modifiers.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform

AISAP Cardio vs Rapid Enterprise Platform

AngioWaveNet vs Rapid Enterprise Platform

CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring CAC Software or KardiaAI

Backers

Who funded each tool's parent company.